Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Payables (2016 - 2025)

Skinvisible's Payables history spans 16 years, with the latest figure at $1.5 million for Q3 2025.

  • For Q3 2025, Payables fell 2.78% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, down 2.78%, while the annual FY2024 figure was $858993.0, 79.45% up from the prior year.
  • Payables for Q3 2025 was $1.5 million at Skinvisible, up from $1.4 million in the prior quarter.
  • Across five years, Payables topped out at $4.0 million in Q3 2022 and bottomed at $166057.0 in Q1 2023.
  • The 5-year median for Payables is $1.4 million (2025), against an average of $1.8 million.
  • The largest annual shift saw Payables soared 1522.78% in 2021 before it crashed 95.23% in 2023.
  • A 5-year view of Payables shows it stood at $3.4 million in 2021, then tumbled by 63.71% to $1.2 million in 2022, then plummeted by 61.46% to $478668.0 in 2023, then skyrocketed by 79.45% to $858993.0 in 2024, then soared by 75.64% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Payables are $1.5 million (Q3 2025), $1.4 million (Q2 2025), and $1.3 million (Q1 2025).